EVALUATING THE EFFICIENCY OF BREATHING EXERCISES PERFORMED BY POST-COVID TELEMEDICINE: Randomized Controlled Study
1 other identifier
interventional
52
1 country
1
Brief Summary
As an important non-drug intervention in the treatment of respiratory tract diseases, respiratory rehabilitation training is increasingly accepted in clinical practice. The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly. In light of the widely documented lung injuries associated with COVID-19, concerns are raised regarding the assessment of lung injury in discharged patients. As an important non-drug intervention in the treatment of respiratory diseases, respiratory rehabilitation training is increasingly being accepted in clinical practice The purpose of pulmonary rehabilitation is not only to improve the physical and mental conditions of the patient, but also to help the patient return to the family and society more quickly. The aim of the study; It is aimed to evaluate the efficiency of breathing exercise in individuals with COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2021
CompletedFirst Posted
Study publicly available on registry
February 25, 2021
CompletedStudy Start
First participant enrolled
February 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedFebruary 22, 2022
February 1, 2022
4 months
February 21, 2021
February 5, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
6 minute walking test
6 minute walking test
1 month
FEV-1
FEV-1
1 month
FVC
FVC
1 month
FEV1/FVC
FEV1/FVC
1 month
MVV
MVV- Maximal Voluntary Ventilation
1 month
Secondary Outcomes (1)
St. George's Respiratory Questionnaire
1 month
Study Arms (2)
İntervention
EXPERIMENTALRespiratory exercises will be instructed to the individuals forming the intervention group and participants will be asked to do 3 times a day during one month and the exercises will be done by the researchers together with the individuals by establishing a connection with the phone application (zoom, watsapp) once a week from home. In terms of physical activity, the patient will be encouraged to participate in the program by suggesting exercises such as walking and cycling at least three times a week for 20 minutes per week
Control
OTHERBreathing exercises will be explained to the control group and visual material will be given. The participants will be asked to do 3 times a day during one month. In terms of physical activity, the patient will be encouraged to participate in the program by suggesting exercises such as walking and cycling at least three times a week for 20 minutes per week
Interventions
1. Respiratory Control: 2. Pursed Lip Breathing 3. Diaphragmatic Breathing Respiratory exercises will be instructed to the individuals forming the intervention group and participants will be asked to do 3 times a day during one month and the exercises will be done by the researchers together with the individuals by establishing a connection with the phone application (zoom, watsapp) once a week from home.
1. Respiratory Control: 2. Pursed Lip Breathing 3. Diaphragmatic Breathing Breathing exercises will be explained to the control group and visual material will be given. The participants will be asked to do 3 times a day during one month. In terms of physical activity, the patient will be encouraged to participate in the program by suggesting exercises such as walking and cycling at least three times a week for 20 minutes per week
Eligibility Criteria
You may qualify if:
- years of age or older and who received / will receive treatment with the diagnosis of COVID 19 and completed 2 months after the diagnosis of COVID 19
- Patients who applied to the Pulmonary Diseases outpatient clinic with complaints of dyspnea
- FEV1 / FVC \<80%, FVC \<80%, FEV1 \<80%, FEF25-75\> 50% and / or Patients with respiratory distress in daily living activities
You may not qualify if:
- FEV 1 \<50%, FEF 25-75 \<50% detected oxygen saturation \<85% at rest,
- moderately severe heart failure,
- has a disease that restricts its mobilization,
- psychiatric illness,
- advanced stage liver, advanced stage renal failure,
- Myocardial infarction within 4 months
- having a history of unstable angina
- active infectious disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tokat State Hospital
Tokat Province, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof.
Study Record Dates
First Submitted
February 21, 2021
First Posted
February 25, 2021
Study Start
February 25, 2021
Primary Completion
June 30, 2021
Study Completion
July 30, 2021
Last Updated
February 22, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share